Franz-Werner Haas
Chief Executive Officer at Curevac Aktiebolag
Net worth: 443 986 $ as of 2024-03-30
Profile
Dr. Franz-Werner Haas is a Chief Executive & Operating Officer at Curevac Aktiebolag, a Chief Executive Officer at CureVac AG and a Chief Executive Officer at CureVac NV. Dr. Haas was previously employed as a Chief Compliance Officer & VP-Operations by Expedeon AG, a General Counsel by Sirona Dental Systems, Inc., and a General Counsel by Lion Bioscience, Inc. He received his graduate degree from The University of Edinburgh and a graduate degree from Universität Saarbrücken.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CUREVAC N.V.
0.07% | 2023-03-30 | 146,530 ( 0.07% ) | 443 986 $ | 2024-03-30 |
Franz-Werner Haas active positions
| Companies | Position | Start |
|---|---|---|
Curevac Aktiebolag
 Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The private company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012. | Chief Executive Officer | 2020-08-03 |
LimmaTech Biologics AG
 LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Chief Executive Officer | 2023-07-18 |
Former positions of Franz-Werner Haas
| Companies | Position | End |
|---|---|---|
| CUREVAC N.V. | Chief Executive Officer | 2023-03-30 |
| 2INVEST AG | Compliance Officer | 2012-02-29 |
| SIRONA DENTAL SYSTEMS, INC. | General Counsel | 2005-04-30 |
Lion Bioscience, Inc.
 Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | General Counsel | 2004-11-30 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chief Executive Officer | - |
Training of Franz-Werner Haas
| The University of Edinburgh | Graduate Degree |
| Universität Saarbrücken | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| 2INVEST AG | Finance |
| CUREVAC N.V. | Health Technology |
| Private companies | 5 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Sirona Dental Systems, Inc.
 Sirona Dental Systems, Inc. Medical SpecialtiesHealth Technology Sirona Dental Systems, Inc. was developing, manufacturing and marketing dental equipment. Its products include CAD/CAM restoration systems, imaging systems, treatment centers, instruments, and cabinetry. The company was founded on October 1, 1997 and was headquartered in York, PA. | Health Technology |
Lion Bioscience, Inc.
Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | Commercial Services |
Curevac Aktiebolag
Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The private company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012. | Process Industries |
LimmaTech Biologics AG
LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Commercial Services |
- Stock Market
- Insiders
- Franz-Werner Haas
